Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 17,939 | 14,669 | 14,330 | 10,050 | 69,821 |
| Cost of Goods | 15,679 | 12,947 | 11,949 | 8,647 | 49,668 |
| Gross Profit | 2,260 | 1,721 | 2,381 | 1,403 | 20,153 |
| Operating Expenses | 60,680 | 39,477 | 33,716 | 36,055 | 39,700 |
| Operating Income | -57,741 | -36,809 | -30,386 | -34,005 | -18,878 |
| Interest Expense | 756 | 281 | 1,577 | 2,648 | 481 |
| Other Income | 2,926 | -1,615 | -4,314 | 2,086 | 513 |
| Pre-tax Income | -55,571 | -38,705 | -36,277 | -34,566 | -18,846 |
| Income Tax | -104 | 780 | -176 | N/A | 551 |
| Net Income Continuous | -55,466 | -39,485 | -36,101 | -34,566 | -19,397 |
| Net Income Discontinuous | N/A | N/A | -30,268 | -22,017 | N/A |
| Minority Interests | -593 | -504 | -12,600 | -9,448 | 3,909 |
| Net Income | $-54,873 | $-38,981 | $-53,770 | $-47,135 | $-23,306 |
| EPS Basic Total Ops | -251.87 | -284.86 | -599.70 | -809.60 | -689.66 |
| EPS Basic Continuous Ops | -253.87 | -288.83 | -388.31 | -584.71 | -563.23 |
| EPS Basic Discontinuous Ops | N/A | N/A | -194.90 | -224.89 | N/A |
| EPS Diluted Total Ops | -251.87 | -284.86 | -599.70 | -809.60 | -689.66 |
| EPS Diluted Continuous Ops | -253.87 | -288.83 | -388.31 | -584.71 | -563.23 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -194.90 | -224.89 | N/A |
| EBITDA(a) | $-55,502 | $-35,203 | $-27,226 | $-30,124 | $-12,903 |